AOD-9604 Dosing Protocols Based on Clinical Research Dosing recommendations for AOD-9604 are based on extensive human research including six clinical trials that evaluated various administration routes, doses, and treatment durations
Patients with pernicious anemia This autoimmune condition destroys intrinsic factor, the protein required for B12 absorption in the small intestine

Research-grade specs Class: Small-molecule NNMT inhibitor (not a peptide) Molecular weight: 177 g/mol Vial size: 50 mg Format: Lyophilized powder Mechanism studied: NNMT inhibition and intracellular NAD availability Studied applications NNMT enzyme-inhibition research NAD pathway and cellular energy signalling studies Adipocyte metabolism research in cell culture Mitochondrial function and cellular aging marker studies Quality & trust 99% HPLC purity, third-party tested Mass spectrometry identity confirmation LAL endotoxin testing on every batch Batch-specific Certificate of Analysis included cGMP manufactured in Dallas, Texas (USA) USA same-day shipping (orders before 2pm CT M-F) Free domestic shipping on orders over $200 Not sold or shipped outside the United States Storage & handling Store the vial refrigerated at 28C, protected from light and heat Reconstitute with bacteriostatic water

Compound Specifications Why Research Laboratories Select 5-Amino-1MQ 5-Amino-1MQ is the most widely referenced selective NNMT inhibitor in current enzyme biology and methylation pathway research
It is a research-use ingredient, not a systemic drug, and it is not FDA-approved